rAAVrh74.MCK.Micro-Dystrophin (Nationwide Children’s Hospital) | Interleukin Related interleukin-related.com

Product Name :
rAAVrh74.MCK.Micro-Dystrophin (Nationwide Children’s Hospital)

Search keywords :
Dysferlin

drugId :
null

Target Vo:
Dysferlin

Target Vo Short Name :
DYSF

Moa_Name:
Dysferlin gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nationwide Children’S Hospital

Active Company_Name :
Nationwide Children’S Hospital

Active Indication_Name:
Muscular Dystrophy, Duchenne

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Adiponectin Antibody
c-Myc Antibody
CPT1A Antibody: CPT1A Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CPT1A polyclonal antibody. CPT1A Antibody can be used for: WB, ELISA expriments in mouse, and predicted: human, rat background without labeling.

Author: Interleukin Related

Related Posts